Doro AB

  • ISIN: SE0000215493
  • Land: .

Nachricht vom 21.03.2012 | 17:00

Bulletin from Doro AB’s Annual General Meeting 2012


Doro AB 

21.03.2012 17:00
---------------------------------------------------------------------------

Lund, Sweden, 2012-03-21 17:00 CET (GLOBE NEWSWIRE) -- 

At the Annual General Meeting of Doro AB (publ), held on 21 March 2012, it was
resolved, inter alia: 

* to adopt the income statement and balance sheet, and the consolidated income
statement and the consolidated balance sheet; 
* to distribute a dividend of SEK 1 per share for the financial year 2011;
* to discharge from liability the members of the board of directors and the CEO
for the financial year 2011; 
* to re-elect Bo Kastensson, Karin Moberg, Jonas Mårtensson, Jérôme Arnaud and
Charlotta Falvin as members of the board of directors for the period up to and
including the next annual general meeting; 
* to re-elect Bo Kastensson as the chairman of the board of directors;
* remuneration to the board as follows: the chairman receives SEK 350,000 and
other members not employed by the company receive SEK 150,000 each; 
* to adopt principles for the appointment of the nomination committee;
* to authorize the board, for the period until the next annual general meeting,
to resolve, on one or several occasions, to issue not more than 1,930,000
shares without preferential rights for the shareholders. Such new issue
resolution shall include a provision that new shares shall be paid in kind; and 
* to adopt remuneration guidelines with the principal effect that salaries and
other terms of remuneration for the group management shall be on market terms. 



For more information, please contact:
President and CEO Jérôme Arnaud, +46 (0)46 280 50 05,
or Vice President and CFO Annette Borén, +46 (0)706 30 00 09.

This is information that Doro AB (publ) is required to publish in accordance
with the Swedish Securities Markets Act and/or the Swedish Financial Trading
Act. This information was submitted for publication on March 21, 2012 at 5 p.m
CET.
News Source: NASDAQ OMX



21.03.2012 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Doro AB
              
               
              Sweden
Phone:        
Fax:          
E-mail:       
Internet:     
ISIN:         SE0000215493
WKN:          
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------

Anleihe im Fokus

Das APASSIONATA-Wertpapier – Investition in Leidenschaft


Zinssatz: 8,125% p.a., rückwirkende jährliche Zahlung
Zeichnungsfrist: 26. und 27. März 2015
Stückelung: 1.000 EUR
Emission: bis zu 30.000.000 €, festverzinsliche Teilschuldverschreibung
WKN: A14J88
ISIN: DE000A14J884

GBC-Research im Fokus

CytoTools AG: Verzögerungen in Indien, aber positiver Verlauf in Europa

Die CytoTools AG gab am 4. März 2015 bekannt, dass es bei der Zulassung des Wundheilpräparates DermaPro in Indien zu Verzögerungen kommt. Die für den europäischen Markt bestimmten Indikationen DFU und VLU liefen aber weiterhin planmäßig. GBC-Analyst Cosmin Filker hat mit dem CytoTools-Vorstand Dr. Freyberg über die Entwicklung in Indien, aber auch über den positiven Verlauf der europäischen Zulassung für DermaPro gesprochen.

Aktueller Webcast

DO Deutsche Office AG

Annual Report 2014

26. März 2015

Aktuelle Research-Studie

USU Software AG

Original-Research: USU Software AG (von GBC AG):

27. März 2015